A detailed history of Graney & King, LLC transactions in Amgen Inc stock. As of the latest transaction made, Graney & King, LLC holds 150 shares of AMGN stock, worth $44,499. This represents 0.03% of its overall portfolio holdings.

Number of Shares
150
Holding current value
$44,499
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$258.78 - $328.31 $38,816 - $49,246
150 New
150 $39.1 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $159B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Graney & King, LLC Portfolio

Follow Graney & King, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graney & King, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graney & King, LLC with notifications on news.